Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients. The US ...

Depleting a clotting protein from the liver may help slow pancreatic cancer, according to a new study conducted by a team of researchers at the Indiana University Melvin and Bren Simon Comprehensive ...

Pancreatic cancer is one of the most aggressive and deadly forms of cancer. It is often diagnosed at a late stage, when the disease has already spread to other organs such as the liver. Because of ...

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have found that depleting a clotting protein made by the liver could slow down pancreatic cancer.

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have found that depleting a clotting protein ...

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Corifact Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...

Allied Market Research published a report, titled, "Fibrinogen Concentrate Market by Product Type (Human Fibrinogen ...

Figure 1. Fibrinogen synthesis and expression. Fibrinogen synthesis is regulated by both transcriptional and translational mechanisms. After individual fibrinogen chains are translated, fibrinogen ...